Page last updated: 2024-10-30

lansoprazole and Pancytopenia

lansoprazole has been researched along with Pancytopenia in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bay, A1
Coskun, E1
Leblebisatan, G1
Yalcin, AS1
Marshall, RW1
Marshall, VJ1
Hull, R1

Other Studies

2 other studies available for lansoprazole and Pancytopenia

ArticleYear
Helicobacter pylori infection-related pancytopenia in a young boy.
    Pediatric hematology and oncology, 2011, Volume: 28, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anemia, Megaloblastic; Anti-Bacter

2011
Disease-modifying anti-rheumatic drugs are only one of a number of potential causes of myelosuppression: a careful drug history is necessary to elucidate the cause of an adverse event.
    Rheumatology (Oxford, England), 2006, Volume: 45, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Infective Agents; Antirheumatic Agents; Arthriti

2006